Association of race with complications and prognosis following acute coronary syndromes

Craig R Asher; David J Moliterno; Manjushri V Bhapkar; Darren K McGuire; Sunil V Rao; David R Holmes; L Kristin Newby; Eric R Bates; Eric J Topol; SYMPHONY and 2nd SYMPHONY Investigators

doi:10.1016/j.amjcard.2004.05.069

Association of race with complications and prognosis following acute coronary syndromes

Am J Cardiol. 2004 Sep 15;94(6):792-4. doi: 10.1016/j.amjcard.2004.05.069.

Authors

Craig R Asher¹, David J Moliterno, Manjushri V Bhapkar, Darren K McGuire, Sunil V Rao, David R Holmes, L Kristin Newby, Eric R Bates, Eric J Topol; SYMPHONY and 2nd SYMPHONY Investigators

Affiliation

¹ Department of Cardiology, The Cleveland Clinic Foundation, Weston, Florida, USA.

PMID: 15374792
DOI: 10.1016/j.amjcard.2004.05.069

Abstract

The baseline characteristics, complications, and survival of 489 black and 6,890 non-black patients with acute coronary syndromes were studied. Important racial differences were observed in demographic features, atherosclerosis risk factors, and treatment strategies; however, despite these differences, no independent difference was observed in clinical outcomes according to race. The 1-year mortality rate was 2.9% for black patients and 2.5% for non-black patients (p = 0.93).

Publication types

Clinical Trial
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Acute Disease
Aged
Black or African American*
Coronary Disease / complications*
Coronary Disease / drug therapy
Coronary Disease / ethnology*
Coronary Disease / mortality
Double-Blind Method
Female
Humans
Male
Middle Aged
Multivariate Analysis
Oximes / therapeutic use
Piperidines / therapeutic use
Platelet Aggregation Inhibitors / therapeutic use
Prognosis
Retrospective Studies
Risk Factors

Substances

Oximes
Piperidines
Platelet Aggregation Inhibitors
sibrafiban